A total of 120 products have been accepted onto the European Medicines Agency's PRIME (priority medicines) scheme since it was launched in 2016, with Janssen leading the pack when it comes to the companies with the most entries in the scheme.
Six products from Janssen have been granted PRIME designation, although one of them has since been withdrawn from the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?